Bone Growth Stimulator Market - Industry Size, Share, Growth & Forecast 2028 | UnivDatos

 

Global Bone Growth Stimulator Market is expected to register a CAGR of approx. 5% over the period of 2022-2028.  The global bone growth stimulator market is rising due to the growing number of trauma, accident cases, and bone fractures across the globe.  For instance, according to studies in 2020, One of the factors causing bone fractures is Road Traffic Accidents (RTAs), which are the first leading cause of death among people aged 15-29 years. In 2019, the global number of new cases of fracture was estimated to be 178 million (95%), an increase of 33·4% since 1990. Owing to these glaring statistics road accidents and trauma are likely to result in several severe spinal injuries which increases the demand for bone growth stimulators and is anticipated to grow in the forthcoming years mainly. According to UnivDatos Market Insights (UMI)’ research report “Global Bone Growth Stimulator Market”, the market is expected to witness robust growth during the forecast period 2022-2028F. Moreover, the surge in patient awareness regarding bone growth stimulators, and procedural benefits provided by bone growth stimulation devices in bone fracture treatment and orthopedic diseases are fueling the demand for the bone growth stimulator market. Furthermore, the rise in technological advancements in bone growth stimulators, and the increase in adoption rate for bone growth stimulators by both patients and prescribers are expected to drive the market for bone growth stimulator market in the coming years.

Unlock The Table of Content, And Request a Sample Report - https://univdatos.com/get-a-free-sample-form-php/?product_id=28011

Based on the product, the bone growth stimulator market is segmented into bone growth stimulation devices, bone morphogenetic proteins, and platelet-rich plasma. The bone growth stimulation devices segment accounted for a significant market share and it is estimated that it will grow rapidly during the projected timeframe owing to the rise in the geriatric population, and the increase in the incidence of spinal deformities.

Based on the end-users, the market is fragmented into hospitals and clinics, home care, and others. The hospital segment grabbed a considerable market share, and it is expected to grow at a significant CAGR during the forecast period owing to increasing admission of patients suffering from traumatic injuries, road accidents, spinal injuries, and fractures.

North America witnessed extensive growth

For a better understanding of the market adoption of the bone growth stimulator market, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom, and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America constitutes a major market for the bone growth stimulator industry to the high prevalence of osteoporosis or vertebral fractures, rise in the number of bone and joint problems, the large presence of medical device companies, and well-developed healthcare infrastructure.

For More Informative Information, Please Visit Us – https://univdatos.com/report/bone-growth-stimulator-market/

According to UnivDatos Market Insights (UMI)’, the key players with a considerable market share in the global bone growth stimulator market are Orthofix Medical Inc., DJO Finance, LLC, Zimmer Biomet Holdings Inc, Bioventus Inc, Medtronic PLC, Isto Biologics, Ember Therapeutics Inc, Ossatec Benelux Ltd., Elizur Corporation, Kinex Medical Company LLC Several M&A’s along with partnerships have been undertaken by these players to boost their presence in different regions.

“Global Bone Growth Stimulator Market” provides comprehensive qualitative and quantitative insights on the industry potential, key factors impacting sales and purchase decisions, hotspots, and opportunities available for the market players. Moreover, the report also encompasses the key strategic imperatives for success for competitors along with strategic factorial indexing measuring competitor's capabilities on different parameters. This will help companies in the formulation of go-to-market strategies and identifying the blue ocean for its offerings.        

Market Segmentations:

1.      By Product (Bone Growth Stimulation Devices, Bone Morphogenetic Proteins, Platelet-rich Plasma)

2.      By Application (Spinal fusion surgeries, Delayed union & non-union bone fractures, Oral and maxillofacial surgeries, Others)

3.      By End-User (Hospitals and clinics, Home care, Others)

4.      By Region (North America, Europe, Asia-Pacific, Rest of the World)

5.      By Company (Orthofix Medical Inc., DJO Finance, LLC, Zimmer Biomet Holdings Inc, Bioventus Inc, Medtronic PLC, Isto Biologics, Ember Therapeutics Inc, Ossatec Benelux Ltd., Elizur Corporation, Kinex Medical Company LLC)

Key questions answered in the study:

1.      What are the current and future trends of the global bone growth stimulator industry?

2.      How the industry has been evolving in terms of product, application, and end-users?

3.      How the competition has been shaping across the countries followed by their comparative factorial indexing?

4.      What are the key growth drivers and challenges for the global bone growth stimulator industry?

5.      What is the customer orientation, purchase behavior, and expectations from the global bone growth stimulator suppliers across various region and countries?